Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Income from Continuing Operations (2017 - 2026)

Updated

Amneal Pharmaceuticals' Income from Continuing Operations came in at $12.31 million for Q3 2026, down 32.1% from $18.13 million a year earlier and down 82.3% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Income from Continuing Operations (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Amneal Pharmaceuticals reported Income from Continuing Operations of $209.49 million, up 263.6% year-over-year; for FY2025, it came in at $127.93 million.

  • Income from Continuing Operations carries a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
  • Going back by year, Income from Continuing Operations was -$73.88 million in FY2024, -$48.72 million in FY2023, -$254.83 million in FY2022 and $20.17 million in FY2021 (-70.6%).
  • The Q3 2026 figure represents the lowest quarterly Income from Continuing Operations since Q4 2024.
  • Year-over-year, Income from Continuing Operations increased in four of the last five quarters, with growth averaging 89.3%.
  • Business Quant data shows AMRX's Income from Continuing Operations at $69.61 million (Q2 2026), $78 million (Q1 2026) and $49.57 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.80 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.25 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 12.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.31 Mn
Jun 30, 2026 69.61 Mn
Mar 31, 2026 78.00 Mn
Dec 31, 2025 49.57 Mn
Sep 30, 2025 18.13 Mn
Jun 30, 2025 35.61 Mn
Mar 31, 2025 24.62 Mn
Dec 31, 2024 -20.74 Mn
Sep 30, 2024 11.76 Mn
Jun 30, 2024 16.79 Mn
Mar 31, 2024 -81.68 Mn
Dec 31, 2023 -93.34 Mn
Sep 30, 2023 25.06 Mn
Jun 30, 2023 29.68 Mn
Mar 31, 2023 -10.13 Mn
Dec 31, 2022 -5.86 Mn
Sep 30, 2022 -2.42 Mn
Jun 30, 2022 -240.13 Mn
Mar 31, 2022 -6.42 Mn
Dec 31, 2021 -20.42 Mn
API Access

Amneal Pharmaceuticals Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=AMRX&period=max&api_key=YOUR_API_KEY